NRx Pharmaceuticals Announces Closing of $6.28 Million Registered Direct Offering ...Middle East

PR Newswire - News
RADNOR, Pa., June 9, 2023 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), ("NRx Pharmaceuticals" or the "Company"), a clinical-stage biopharmaceutical company, today announced that it has closed its previously announced registered direct offering for the purchase and sale of...

Hence then, the article about nrx pharmaceuticals announces closing of 6 28 million registered direct offering was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( NRx Pharmaceuticals Announces Closing of $6.28 Million Registered Direct Offering )

Apple Storegoogle play

Last updated :

Also on site :